EUVIMEDEUVIMED entdecken
Open Access

Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug Resistance

Rabindranath Bera, Yotaro Ochi, Ying-Jung Huang, Ming-Chung Kuo, Kenichi Yoshida, Seishi Ogawa, Lee-Yung Shih

Oncology Research · 2026

DOI: 10.32604/or.2025.070259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Rabindranath Bera und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Chang Gung Memorial Hospital-Linkou, Taoyuan City, 333, Taiwan. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Drug Resistance, Neoplasm, Mutation, Microtubule-Associated Proteins. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveDrug Resistance, NeoplasmMutationMicrotubule-Associated ProteinsHumansAnimalsMiceCell ProliferationApoptosisK562 CellsSTAT3 Transcription FactorImatinib MesylateFusion Proteins, bcr-ablProtein Kinase InhibitorsXenograft Model Antitumor AssaysCell Line, TumorKinesins

Stichwörter der Autor:innen

Chronic myeloid leukemia (CML)drug resistancekinesin light chain 2 (KLC2)myeloid blast transformationsignal transducer and activator of transcription 3 (STAT3)

Substanzen

STAT3 Transcription FactorImatinib MesylateMicrotubule-Associated ProteinsFusion Proteins, bcr-ablProtein Kinase InhibitorsSTAT3 protein, humanKlc2 protein, mouseKinesins

Autor:innen und Institutionen

  • Division of Hematology-Oncology, Chang Gung Memorial Hospital-Linkou, Taoyuan City, 333, Taiwan.
  • Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, 6068501, Japan.
  • Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, 6068501, Japan.
  • School of Medicine, Chang Gung University, Taoyuan City, 333, Taiwan.
  • Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, 1040045, Japan.

Zitieren

APA

Bera, R., Ochi, Y., Huang, Y. J., Kuo, M. C., Yoshida, K., Ogawa, S., & Shih, L. Y. (2026). Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug Resistance. Oncology Research. https://doi.org/10.32604/or.2025.070259

Vancouver

Bera R, Ochi Y, Huang YJ, Kuo MC, Yoshida K, Ogawa S, et al. Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug Resistance. Oncology Research. 2026. doi:10.32604/or.2025.070259

BibTeX
@article{Bera2026,
  author = {Bera, Rabindranath and Ochi, Yotaro and Huang, Ying-Jung and Kuo, Ming-Chung and Yoshida, Kenichi and Ogawa, Seishi and Shih, Lee-Yung},
  title = {Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug Resistance},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2025.070259}
}
Kostenlos starten →